Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2000
03/30/2000WO2000016791A1 Myrtle extract, preparation method and use
03/30/2000WO2000016783A1 Method of preventing acute lung injury
03/30/2000WO2000016782A1 Pharmaceutical compositions of vanadium biguanide complexes and their use
03/30/2000WO2000016781A1 Chk1 kinase inhibitors
03/30/2000WO2000016780A1 Optimized use of 6-mercaptopurine drug in the treatment of immune-mediated gastrointestinal disorders
03/30/2000WO2000016779A1 Antiviral combinations comprising lamivudine and abacavir
03/30/2000WO2000016778A1 A method of treating cancer
03/30/2000WO2000016777A1 Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas
03/30/2000WO2000016775A1 Topical formulation of alkyl-, phenyl-pyridone
03/30/2000WO2000016774A1 Method for solubilizing pyridonecarboxylic acid, solubilizer therefor, aqueous solution preparations containing pyridonecarboxylic acid and process for producing the same
03/30/2000WO2000016773A1 Pharmaceutical composition containing an angiotensin ii at1 receptor antagonist and an antiplatelet agent
03/30/2000WO2000016772A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
03/30/2000WO2000016771A1 Liquid preparations for external use containing sodium cromoglicate and method for treating or preventing eye allergic symptoms
03/30/2000WO2000016770A1 Pharmaceutical preparation containing taxane and method for producing the same
03/30/2000WO2000016769A1 ACTIVE ENANTIOMER OF RARη-SPECIFIC AGONIST
03/30/2000WO2000016768A1 Cxcr2 inhibitors and pmn adhesion and t-cell chemotaxis
03/30/2000WO2000016766A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
03/30/2000WO2000016765A1 Method and composition for treatment of inflammatory bowel disease
03/30/2000WO2000016764A2 Pharmaceutical compositions comprising derivatives of sulphur acids
03/30/2000WO2000016763A2 Antimalarial agents
03/30/2000WO2000016762A2 Method for reducing nicotine dependency
03/30/2000WO2000016761A2 Serotonergic 5ht2 agonists for treating glaucoma
03/30/2000WO2000016760A2 New use of prostaglandin e2 antagonists
03/30/2000WO2000016759A2 Genistein for the treatment of coronary heart disease and for the prevention of restenosis after percutaneous transluminal coronary angioplasty
03/30/2000WO2000016758A2 Treatment of infection
03/30/2000WO2000016757A2 Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants
03/30/2000WO2000016756A2 Use of n-acylvanillinamide derivatives as agonists of peripheral cannabinoid cb1 receptors
03/30/2000WO2000016755A2 Antiviral combinations of lamivudine and adefovir
03/30/2000WO2000016754A2 Antiviral combinations comprising lamivudine and lobucavir
03/30/2000WO2000016753A2 Use of nucleosides, nucleobases and their derivatives for reducing the thrombocytopenic side effects of cytostatic agents
03/30/2000WO2000016751A1 Fentanyl composition for the treatment of acute pain
03/30/2000WO2000016750A1 Pharmaceutical composition for the treatment of acute disorders
03/30/2000WO2000016749A1 Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications
03/30/2000WO2000016748A1 Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
03/30/2000WO2000016747A1 Agitation-independent pharmaceutical multiple unit retard preparations and method for the production thereof
03/30/2000WO2000016745A2 Micronised pharmaceutical compositions
03/30/2000WO2000016739A1 Use of at least a10-hydroxy-2- decenoic acid derivative in a composition for promoting skin scaling
03/30/2000WO2000016736A1 Oral care compositions
03/30/2000WO2000016732A2 ANTI-MICROBIAL-ADHESION FRACTION DERIVED FROM $i(VACCINIUM)
03/30/2000WO2000016632A2 Environmentally benign crop protection agents
03/30/2000WO2000016631A1 Murf2
03/30/2000WO2000016624A1 Safe and effective biofilm inhibitory compounds and health-related uses thereof
03/30/2000WO2000016623A1 Antifouling agents
03/30/2000WO2000016621A1 Compositions and methods for the treatment of chronic lymphocytic leukemia
03/30/2000WO2000016603A2 Bridged heterocyclic derivatives
03/30/2000WO2000009096B1 Injectable formulations of nanoparticulate naproxen
03/30/2000WO2000007576A3 INHIBITORS OF TYPE 3 3α-HYDROSTEROID DEHYDROGENASE
03/30/2000WO2000004016A3 Polymorph of ritonavir
03/30/2000WO2000003680A3 Emollient esters based upon capryl alcohol and isostearic acid
03/30/2000WO2000000483A9 Tubulin binding compounds (cobra)
03/30/2000WO2000000186A8 Method of treating topical ailments
03/30/2000WO2000000182A3 Medicaments containing bisphosphonic acids and derivatives thereof which are provided for preventing and treating autoimmune diseases and allergies
03/30/2000WO2000000120A9 Methods and transdermal compositions for pain relief
03/30/2000WO1999067212A3 Active carbon filter as an oxidation inhibitor for prostane derivatives
03/30/2000WO1999066918A9 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
03/30/2000WO1999065449A3 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
03/30/2000WO1999063931A9 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
03/30/2000WO1999062908A3 Cell adhesion-inhibiting antinflammatory compounds
03/30/2000WO1999061066A9 Convection-enhanced delivery of aav vectors
03/30/2000DE19944695A1 Method for strengthening the antitumor activity of a crude drug containing polysaccharides comprises roasting the crude drug by far infrared rays followed by fermentation using microorganisms
03/30/2000DE19845830A1 Aminoalkyl-3,4-dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln Aminoalkyl-3,4-dihydroquinoline derivatives and their use in medicaments
03/30/2000DE19844547A1 Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Polycyclic Dihydrothiazole, processes for their preparation and their use as medicaments
03/30/2000DE19844162A1 Medicament combination for treating erectile dysfunction, containing sildenafil and blood flow behavior improving agent, e.g. midodrine, to improve effect at lower dosages
03/30/2000DE19844003A1 New 3-aminomethylidene-2-indolinone derivatives useful as kinase inhibitors and antiproliferative agents e.g. for treating viral infections, tumors, inflammation or autoimmune disease
03/30/2000DE19843413C1 Neue Salzform von Pantoprazol New salt form of pantoprazole
03/30/2000DE19843223A1 Phosphororganische Verbindungen und ihre Verwendung Organophosphorus compounds and their use
03/30/2000DE19843222A1 Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen Use of organophosphorus compounds for therapeutic and prophylactic treatment of infections
03/30/2000DE19842833A1 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung 2-arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole and 2-Arylalkinylthio-imidazoles as inflammatory inhibitors and inhibitors of cytokine release
03/30/2000CA2820588A1 Pharmaceutical composition for the treatment of acute disorders
03/30/2000CA2629988A1 Pharmaceutical composition for the treatment of acute disorders
03/30/2000CA2345378A1 Neuroimmunophilins for selective neuronal radioprotection
03/30/2000CA2345311A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
03/30/2000CA2345242A1 Anti-microbial-adhesion fraction derived from vaccinium
03/30/2000CA2345233A1 Safe and effective biofilm inhibitory compounds and health-related uses thereof
03/30/2000CA2345232A1 Environmentally benign crop protection agents
03/30/2000CA2345155A1 Use of non-peptidyl compounds for the treatment of insulin related ailments
03/30/2000CA2345111A1 Antifouling agents
03/30/2000CA2344927A1 Phosphonic acids derivatives as inhibitors of ptp-1b
03/30/2000CA2344919A1 Active enantiomer of rar.gamma.-specific agonist
03/30/2000CA2344913A1 Antimalarial agents
03/30/2000CA2344867A1 Use of aminoalkylphosphonic acid derivatives for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants
03/30/2000CA2344670A1 Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas
03/30/2000CA2344657A1 Human isre-binding protein
03/30/2000CA2344556A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
03/30/2000CA2344440A1 Antibody directed enzyme prodrug therapy (edept) with glucoronidase
03/30/2000CA2344438A1 Method and composition for treatment of inflammatory bowel disease
03/30/2000CA2344390A1 Interleukin-5 inhibiting 6-azauracil derivatives
03/30/2000CA2344376A1 Bridged heterocyclic derivatives
03/30/2000CA2344310A1 5,6-dihydronaphthalenyl derivatives having retinoid-like activity
03/30/2000CA2344262A1 4-aminopyrrolopyrimidines as kinase inhibitors
03/30/2000CA2344251A1 Tetrahydropyridoethers
03/30/2000CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000CA2344224A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000CA2344172A1 Antiviral combinations
03/30/2000CA2344150A1 Serotonergic 5ht2 agonists for treating glaucoma
03/30/2000CA2343919A1 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
03/30/2000CA2343645A1 Process for obtaining hmg-coa reductase inhibitors of high purity
03/30/2000CA2343391A1 3-bicycloindole compounds as 5-ht1d ligands
03/30/2000CA2343321A1 Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug
1 ... 6341 6342 6343 6344 6345 6346 6347 6348 6349 6350 6351 6352 6353 6354 6355 6356 6357 6358 6359 6360 6361 ... 7860